AP NEWS

CLASS ACTION UPDATE for ABBV and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

November 19, 2018

NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

AbbVie Inc. (NYSE: ABBV) Class Period: October 25, 2013 - September 18, 2018 Lead Plaintiff Deadline: November 20, 2018 Join the action: https://www.zlk.com/pslra-1/abbvie-inc-loss-form?wire=3

Allegations: AbbVie Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) AbbVie’s strategy to increase the sales growth of its blockbuster drug, HUMIRA, relied in part upon illegal kickbacks and unlawful sales and marketing tactics; (2) such practices would foreseeably lead to heightened scrutiny by State governments and agencies; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

To learn more about the AbbVie Inc. class action, contact jlevi@levikorsinsky.com.

Alnylam Pharmaceuticals, Inc. (NASDAQGS: ALNY) Class Period: February 15, 2018 - September 12, 2018 Lead Plaintiff Deadline: November 26, 2018 Join the action: https://www.zlk.com/pslra-1/alnylam-pharmaceuticals-inc-loss-form?wire=3

Allegations: Alnylam Pharmaceuticals, Inc. made materially false and/or misleading statements throughout the class period and/or failed to disclose that: (1) Alnylam overstated the efficacy and safety of its Onpattro (patisiran) lipid complex injection; and (2) as a result, Alnylam’s public statements were materially false and misleading at all relevant times.

To learn more about the Alnylam Pharmaceuticals, Inc. class action, contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Levi & Korsinsky, LLPJoseph E. Levi, Esq.55 Broadway, 10th FloorNew York, NY 10006 jlevi@levikorsinsky.com Tel: (212) 363-7500Toll Free: (877) 363-5972Fax: (212) 363-7171 www.zlk.com

AP RADIO
Update hourly